The key finding
A 2024 review published in the International Journal of Molecular Sciences examines how naturally derived compounds used in Traditional Chinese Medicine (TCM) might influence chronic kidney disease (CKD) progression by affecting two fundamental aging processes: autophagy (the cell’s recycling system) and cellular senescence (when cells stop dividing and become dysfunctional). The authors note that CKD is increasingly viewed as a model of premature aging, and while TCM has shown fewer adverse effects in CKD patients, there remains a significant gap in clinical and molecular studies demonstrating how these natural products work at the cellular level.
What the study looked like
This was a narrative review—not an experimental study with participants, but rather an analysis of existing research on natural products, CKD, autophagy, and cellular senescence. The authors surveyed published literature on TCM compounds that have been used in kidney disease treatment, focusing on their active ingredients and proposed mechanisms. They examined both preclinical studies (cell cultures, animal models) and the limited clinical data available. The review highlights that while some natural compounds show promise in laboratory settings for protecting kidney cells and modulating autophagy or senescence pathways, robust human trials demonstrating therapeutic benefit are scarce. The paper synthesizes what is known about these compounds’ biochemical effects rather than presenting new patient data.
Why researchers think this happened
The authors propose that CKD’s progressive nature shares biological hallmarks with aging: dysfunctional autophagy (which normally clears damaged cellular components) and accumulation of senescent cells (which secrete inflammatory signals). TCM compounds may contain bioactive molecules—such as polyphenols, flavonoids, or saponins—that could restore autophagy function or reduce senescent cell burden, thereby slowing kidney damage. This hypothesis builds on prior work linking autophagy impairment and senescence to age-related diseases beyond the kidney. The review suggests that because TCM has historically been associated with fewer side effects in CKD management, understanding these molecular pathways could help integrate natural products as complementary therapy alongside standard treatments like blood pressure control and dietary modification.
How to read this carefully
This review does not provide clinical trial evidence that TCM compounds effectively treat CKD in humans. The authors explicitly state there is a “lack of clinical and molecular studies” and insufficient research on synergistic effects when multiple compounds are combined. Most supporting data come from cell or animal studies, which often do not translate directly to human outcomes. Because this is a narrative review rather than a systematic meta-analysis, the synthesis may reflect selection bias in which studies were included. Readers should be cautious: association between a compound and a cellular pathway in a lab dish does not mean the compound will safely or effectively alter disease progression in people. No reversal of kidney damage has been demonstrated.
What this means for everyday life
For individuals managing CKD or concerned about kidney health, this review highlights an evolving area of research rather than a ready treatment. It suggests that some natural products may influence aging-related processes in kidneys, but without rigorous clinical trials, it’s premature to rely on them as therapy. If you’re considering TCM or supplements, discuss them with a nephrologist—some natural products can interact with medications or contain contaminants. The review’s takeaway is that conventional CKD care (managing blood pressure, blood sugar, and diet) remains essential, and any complementary approach should be evidence-based. As research progresses, a clearer picture may emerge of which compounds, if any, offer meaningful benefit when combined with standard treatment.